The purchase price, which is confidential and was negotiated for a total of 300 huge number of doses, is slightly lower than the $19.50 a picture the United States agreed to buy a first shipment of 100 million doses of the identical vaccine, in series with what Reuters claimed in November.
The EU file dated Nov. 18 was circulated internally after the EU announced the supply offer of its with Pfizer and its German partner BioNTech on Nov. eleven.
The EU drug regulator is expected to determine on Monday on acceptance for the Pfizer vaccine following the photo was authorised in a number of countries, like Britain as well as the United States.
On Thursday Belgian say secretary on your budget Eva De Bleeker released on Twitter a dining room table with costs Belgium would shell out pharmaceutical companies for the COVID-19 vaccines of theirs. She retracted the article shortly after posting.
In this dining room table the Pfizer vaccine was indicated as costing Belgium 12 euros ($14.6) a dose, top many to believe that has been the full price agreed with the EU.
Other vaccines in the family table were additionally shown with rates lower compared to rates disclosed by EU solutions.
“There is , naturally, a complete cost and a price after delivery,” an EU official required in talks with vaccine creators told Reuters when made to clarify the big difference between the Belgian and EU prices.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament previous week. In that public hearing, De Beeker stated Belgium’s budgeted costs were still partial.
Underneath EU prior purchase deals for COVID 19 vaccines, the bloc agrees upfront payments with business enterprises to secure doses before they are approved. Following approvals, EU governments can pay the rest to purchase reserved doses.
The EU has not revealed the initial payment agreed with Pfizer.
However, it stated in October that it paid aproximatelly 1 billion euros in downpayments to AstraZeneca, Sanofi and Johnson and Johnson for the shots of theirs, with an additional 1.45 billion euros budgeted for upfront payments to Pfizer-BioNTech, Moderna and Curevac.
It’s since agreed source deals with all six corporations and it is negotiating a seventh understanding with Novavax.